Jump To Navigation

OFW Law, a Leader in FDA and USDA Law, Serving Clients Before Federal Agencies, Courts, and Congress 

The U.S. Food and Drug Administration (FDA) regulates more than 25% of the gross domestic product (GDP) of the United States. The U.S. Department of Agriculture (USDA) governs a substantial percentage as well. Whether companies under FDA or USDA jurisdiction are bringing a new product to market, responding to an agency enforcement action, improving or responding to food safety and drug safety practices and needs, or attempting to challenge a new regulatory initiative, businesses regulated by FDA or USDA must know how to navigate the regulatory process. They must also clearly understand the legislative process and how new legislation can impact their businesses. Our attorneys are well situated to anticipate legislative initiatives before Congress, to communicate with our clients about proposed changes, to lobby Congress on their behalf, and to work with federal agencies to ensure the fair and effective implementation of new legislation. The Washington, DC, law firm of OFW Law is the nation's premier FDA and USDA law firm, serving clients before federal agencies, courts, and Congress.

Founded in 1979 as Olsson and Frank, P.C., and known for many years as OFW,  the lawyers and Senior Policy Advisors at OFW Law have built a solid reputation for depth and expertise. Providing legal and bipartisan government affairs representation to companies and trade associations in the food, drug, medical device, and agricultural industries, we work to remove obstacles that our clients face.

With hundreds of years of combined legal and public service experience, as well as backgrounds in government and industry, we have an established reputation for finding solutions to client problems. At OFW Law, we bring a wealth of knowledge and experience to every client we represent.

We are extensively involved in a broad range of issues, including domestic and international food and drug safety policy, energy policy and the increasingly important field of the appropriate use of health information technology. Going forward, we expect to continue these activities, with additional emphasis on the Farm Bill, “Feed the Future” policy, the modernization of USDA and FDA interaction regarding food safety, the anticipated increased regulation of futures markets and the enhancement of physical and technological infrastructure support needed to enhance the success of the agriculture, food, drug and medical device industries.